pharmaphorum
AUGUST 23, 2021
Pfizer and BioNTech’s COVID-19 vaccine was the first to get emergency use authorisation (EUA) from the FDA, and has also become the first to get full regulatory approval in the US. The US has fully vaccinated more than half its total population, but is facing problems with vaccine hesitancy that is slowing down the rollout.
pharmaphorum
AUGUST 18, 2021
The Biden administration has said that it will offer a COVID-19 booster dose to any adult American who was fully vaccinated eight months ago, in light of rising cases of the delta variant and evidence of waning protection with the current jabs. US Surgeon General Vivek Murthy. “This plan was not made lightly. pic.twitter.com/8y7SU5MpHz.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
pharmaphorum
DECEMBER 15, 2020
Hospitals in the US have started vaccinating their front-line staff against COVID-19, as deaths in the country crossed the 300,000 threshold with more than 200,000 new cases reported yesterday. It’s likely to be months before all eligible healthcare workers for the first wave receive vaccinations. First Vaccine Administered.
Pharmaceutical Technology
MAY 1, 2023
After a long period of inactivity in RSV vaccine development , two pharmaceutical companies are now approaching regulatory decisions for their RSV vaccines. Both Pfizer and GSK have major approval decisions regarding the use of their RSV vaccines for older adults this May. What incentivises a country to cover a vaccine?
Expert insights. Personalized for you.
52 
Let's personalize your content